Suchergebnisse - "Hagihara, Mao"

PubPharm (198)

1

Evaluation of effectiveness, hyperkalemia and hepatotoxicity of trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis jirovecii pneumonia in pediatric patients : A single center retrospective study

enthalten in: International journal of antimicrobial agents | 2024

von Kato, H. | Hagihara, M. | Asai, N. | +2

2

INTERFERON PRODUCTION PROMOTER

enthalten in: Europäisches Patentamt | 2024

von HAGIHARA MAO | MIKAMO HIROSHIGE | YAMAGISHI YUKA | +4

3

Association between voriconazole-induced visual hallucination and dopamine: an analysis of the food and drug administration adverse event reporting system database

enthalten in: ResearchSquare.com | 2024

von Kato, H. | Shiraishi, C. | Hagihara, M. | +2

4

Development of a therapeutic drug-monitoring algorithm for outpatients receiving voriconazole : A multicentre retrospective study

enthalten in: British journal of clinical pharmacology | 2024

von Kato, H. | Umemura, T. | Hagihara, M. | +5

5

Comparison of clinical efficacy and safety of baloxavir marboxil versus oseltamivir as the treatment for influenza virus infections : A systematic review and meta-analysis

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2024

von Shiraishi, C. | Kato, H. | Hagihara, M. | +3

6

INTERFERON PRODUCTION PROMOTER

enthalten in: Europäisches Patentamt | 2024

von HAGIHARA MAO | MIKAMO HIROSHIGE | YAMAGISHI YUKA | +4

7

INTERFERON PRODUCTION PROMOTER

enthalten in: Europäisches Patentamt | 2024

von HAGIHARA MAO | MIKAMO HIROSHIGE | YAMAGISHI YUKA | +4

8

Lung cancer progression alters lung and gut microbiomes and lipid metabolism

enthalten in: Heliyon | 2024

von Hagihara, M. | Kato, H. | Yamashita, M. | +7

9

Oral Clostridium butyricum on mice endometritis through uterine microbiome and metabolic alternations

enthalten in: Frontiers in microbiology | 2024

von Hagihara, M. | Ariyoshi, T. | Eguchi, S. | +11

10

Real-World Experience of the Comparative Effectiveness and Safety of Combination Therapy with Remdesivir and Monoclonal Antibodies versus Remdesivir Alone for Patients with Mild-to-Moderate COVID-19 and Immunosuppression : A Retrospective Single-Center Study in Aichi, Japan

enthalten in: Viruses | 2023

von Hirai, J. | Mori, N. | Sakanashi, D. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]